1. Home
  2. Labeler Index
  3. Proficient Rx Lp
  4. 63187-312
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 63187-312 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

The text describes a chart (Figure 1) that shows the probability of achieving a systolic blood pressure of less than 140 mmHg after 8 weeks of treatment with a combination of Valsartan and Hydrochlorothiazide at a dose of 320 mg/25 mg. The chart includes baseline SBP readings ranging from 145 to 180 mmHg. The text also includes some medication dosages for Valsartan and Hydrochlorothiazide, as well as a blood pressure reading of 96 mmHg at the start of the study.*

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

The text describes a figure (Figure 2) that shows the probability of achieving a diastolic blood pressure below 90 mmHg at week 8. The figure includes measurements of baseline DBP in mmHg, ranging from 95 to 105, and a value of 100.*

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

This is a graphic showing the probability of achieving systolic blood pressure less than 130 mmHg at week 8 using Valsartan and Hydrochlorothiazide drugs with respective doses of 320mg and 25mg. The placebo was also included in the study. The baseline SBP (mmHg) ranges from 140 to 180. No further information is available in the given text.*

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

This text appears to be a medical report for a study on the effectiveness of Valsartan and Hydrochlorothiazide in lowering diastolic blood pressure. The study evaluated a dose of 320mg/25mg and showed the probability of achieving diastolic blood pressure <80mmHg at week 8. The graph shows the baseline DBP at mmHg and the probability percentage.*

Valsartan 160mg/12.5mg - valhyctz fig5

Valsartan 160mg/12.5mg - valhyctz fig5

This is a description of a medicine that contains Valsartan HCTZ 160mg / 12.5mg. It comes in a package of 30 dark red colored, ovaloid, biconvex, film-coated tablets with beveled edges. Each tablet is debossed with "I" on one side and "62" on the other. It is made by Aurobindo Pharma Limited, Hyderabad, India and has a product ID of PV031230. The medicine is RX only and must be stored at 20°-25°C (68°-77°F) and kept out of the reach of children. The lot number is 00000, and the expiration date is 00/00/00. The NDC number is 63187-312-30, and it is packaged by Proficient Rx LP in Thousand Oaks, CA.*

Valsartan Chemical Structure - valhyctz str1

Valsartan Chemical Structure - valhyctz str1

Hydrochlorothiazide Chemical Structure - valhyctz str2

Hydrochlorothiazide Chemical Structure - valhyctz str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.